Once-Daily Treatment With Beclomethasone Dipropionate Hydrofluoroalkane Nasal Aerosol (320 mcg/d) Provides Substantial Nasal Symptom Relief in Subjects With Perennial Allergic Rhinitis

被引：0
|
作者：
Prenner, B. M. [1 ]
Weinstein, S. [2 ]
Pleskow, W. [3 ]
Tankelevich, A. [4 ]
Ding, Y. [4 ]
Tantry, S. K. [4 ]
Dorinsky, P. M. [4 ]
机构：
[1] Allergy Associates Med Grp Inc, San Diego, CA USA
[2] Allergy & Asthma Specialists Med Grp, Huntington Beach, CA USA
[3] Warren W Pleskow MD, Encinitas, CA USA
[4] Teva Branded Pharmaceut Prod R&D Inc, Horsham, PA USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2012年 / 129卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2011.12.270
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：AB189 / AB189
页数：1
相关论文
共 50 条
  • [1] Once-Daily Treatment With Beclomethasone Dipropionate Hydrofluoroalkane Nasal Aerosol (320 mcg/d) Is Not Associated With Hypothalamic-Pituitary-Adrenal Axis Suppression in Adolescent Subjects With Perennial Allergic Rhinitis
    Hampel, F. C.
    Ratner, P. H.
    Miller, S. D.
    Melchior, A.
    Dunbar, S. A.
    Tantry, S. K.
    Dorinsky, P. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB188 - AB188
  • [2] Safety and efficacy of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with perennial allergic rhinitis
    Meltzer, Eli O.
    Jacobs, Robert L.
    LaForce, Craig F.
    Kelley, C. Leith
    Dunbar, Stephanie A.
    Tantry, Sudeesh K.
    ALLERGY AND ASTHMA PROCEEDINGS, 2012, 33 (03) : 249 - 257
  • [3] Once-Daily Treatment with Beclomethasone Dipropionate Nasal Aerosol 320 μg Provides 24-Hour Nasal Symptom Relief in Patients with Seasonal Allergic Rhinitis
    Finn, Albert F., Jr.
    Prenner, Bruce
    Nathan, Robert A.
    Ruff, Michael
    Kelley, Leith
    Tantry, Sudeesh
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB114 - AB114
  • [4] Once-Daily Treatment with Beclomethasone Dipropionate Nasal Aerosol Provides Long-Term and Sustained 24-Hour Nasal Symptom Relief in Patients with Perennial Allergic Rhinitis
    Schenkel, Eric R.
    Lumry, William R.
    Kaiser, Harold B.
    Berman, Gary D.
    Ding, Yu
    Tantry, Sudeesh
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB113 - AB113
  • [5] ONCE-DAILY TREATMENT WITH BECLOMETHASONE DIPROPIONATE NASAL AEROSOL IMPROVES NASAL SYMPTOMS OF PERENNIAL ALLERGIC RHINITIS, REGARDLESS OF SYMPTOM SEVERITY AT BASELINE
    Meltzer, E. O.
    Jacobs, R.
    Janka, L.
    Tantry, S. K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A111 - A111
  • [6] Effective Nasal Symptom Relief and Improvement in Health-Related Quality of Life in Subjects with Perennial Allergic Rhinitis Following 6-Week Once-Daily Treatment with Beclomethasone Dipropionate Hydrofluoroalkane Nasal Aerosol
    Carr, W.
    Meltzer, E. O.
    Finn, A.
    Dorinsky, P. M.
    Kelley, L.
    Dunbar, S. A.
    Tantry, S. K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB188 - AB188
  • [7] Efficacy and safety of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with seasonal allergic rhinitis
    van Bavel, Julius H.
    Ratner, Paul H.
    Amar, Niran J.
    Hampel, Frank C., Jr.
    Melchior, Amy
    Dunbar, Stephanie A.
    Dorinsky, Paul M.
    Tantry, Sudeesh K.
    ALLERGY AND ASTHMA PROCEEDINGS, 2012, 33 (05) : 386 - 396
  • [8] Long-Term (52-Week) Treatment With Beclomethasone Dipropionate Hydrofluoroalkane Nasal Aerosol (320 mcg Once Daily) Is Safe and Effective in Adult and Adolescent Subjects With Perennial Allergic Rhinitis
    Nayak, A. S.
    Andrews, C. P.
    Bernstein, D. I.
    Dorinsky, P. M.
    Tankelevich, A.
    Ding, Y.
    Tantry, S. K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB189 - AB189
  • [9] Once-Daily Treatment with Beclomethasone Dipropionate Nasal Aerosol Is Effective in Improving Total Nasal Symptom Scores (TNSS) in Children with Perennial Allergic Rhinitis (PAR) Regardless of Baseline Symptom Severity
    Amar, Niran J.
    Berger, William E.
    Jacobs, Robert L.
    Small, Calvin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB218 - AB218
  • [10] NASAL SYMPTOM IMPROVEMENT FOLLOWING ONCE-DAILY TREATMENT WITH BECLOMETHASONE DIPROPIONATE NASAL AEROSOL (80 μG OR 160 μG) IN CHILDREN WITH SEASONAL ALLERGIC RHINITIS
    Storms, W. W.
    Nayak, N. A.
    Kelley, L.
    Ding, Y.
    Tantry, S. K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A131 - A131
12345